It may regulate the response of cells to drugs and the hypoxia environment by targeting GSK3b, HK2, caspase 3, and caspase 8 through the IL-17 signaling pathway and the TNF signaling pathway and inhibit the proliferation and glycolysis of RA FLS cells. The gene discussed is IL17A; the disease is rheumatoid arthritis.